Digital Generative AI and its impact on speed to market for pharmace... Generative AI (GenAI) is revolutionising the life sciences, and we’re just scratching the surface.
Partner Content Partner Content How clinical trial software can be used to optimize clinical... Automated clinical trial software for efficiencies
Partner Content Partner Content Why switch to automated CRF annotations? Why it's best to automate CRF annotations
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
